• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Direct Flow Medical raises a $32 million in funding round | Medtech funding for the week of December 1, 2014

Direct Flow Medical raises a $32 million in funding round | Medtech funding for the week of December 1, 2014

December 5, 2014 By MassDevice Contributors Network

TAVI: Direct Flow Medical raises $32m, names 1st CCO

December 3, 2014 by Brad Perriello

TAVI: Direct Flow Medical raises $32m, names 1st CCO

Direct Flow Medical said today that it landed a $32 million funding round for its replacement heart valve technology and tapped a 25-year medical device veteran, Chris Richardson, to lead its commercialization program.

Santa Rosa, Calif.-based Direct Flow said the funding round includes a $17 million equity investment led by new backers SV Life Sciences and an unnamed strategic investor. The remaining $15 million comes from the 2nd tranche of a $50 million loan from PDL BioPharma, the company said. Read more

Medtronic prices $17B debt offering for Covidien buy

December 1, 2014 by Brad Perriello

Medtronic prices $17B debt offering for Covidien buy

Medtronic took another big step today toward consummating its $43 billion bid for Covidien, saying it priced priced $17 billion worth of debt to finance the deal.

The 7-tranche offering of senior notes, expected to close Dec. 10, start coming due in 2020, with the final tranche due March 15, 2045, Medtronic said. The proceeds will be used to fund the cash portion of the Covidien buy, the Fridley, Minn.-based company said. Read more

Conventus Orthopaedics raises $24m for arm fracture implants

December 2, 2014 by Brad Perriello

Conventus Orthopedics raises $24m for arm fracture implant

Conventus Orthopaedics said it closed a Series AA round worth $24 million it plans to use to commercialize 1of its self-expanding extremities implants and advance R&D on another.

Minneapolis-based Conventus said the round’s participants included Deerfield Management, Ally Bridge Group, Sightline Partners, Spray Fund, Blue Stem Capital, BioStar Ventures and Blue Sky Fund. The AA round takes its total raise to $34 million, according to a press release, including a $10 million venture debt facility inked last April. Read more

Xeltis raises $34m for regenerative heart valve tech

December 2, 2014 by Brad Perriello

Xeltis raises $34m for regenerative heart valve tech

Xeltis said today that it closed an over-subscribed Series B round worth about $34 billion for the regenerative heart valve technology it’s developing.

Zurich-based Xeltis said the round was led by Amsterdam’s Life Sciences Partners and Paris-based Kurma Partners and included VI Partners and existing shareholders. The proceeds are earmarked primarily for commercialization of the company’s 1st product, a pulmonary valve, and pipeline development, according to a press release. Read more

Filed Under: Funding Roundup, News Well Tagged With: Ally Bridge Group, BioStar Ventures, Blue Sky Fund, Blue Stem Capital, Conventus Orthopaedics, Covidien, Deerfield Management, Direct Flow Medical Inc., Kurma Partners, Life Sciences Partners, PDL BioPharma, Sightline Partners, Spray Fund, SV Life Sciences, VI Partners, Xeltis

More recent news

  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure
  • NanoVibronix enters into $50M financing agreement

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy